DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Information source: Hoffmann-La Roche
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Post-Menopausal Osteoporosis

Intervention: ibandronate [Bonviva/Boniva] (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Hoffmann-La Roche

Official(s) and/or principal investigator(s):
Clinical Trials, Study Director, Affiliation: Hoffmann-La Roche, +1 973 235 5000

Summary

This single arm study will continue drug safety surveillance, and assessment of adherence, in patients with postmenopausal osteoporosis who have received monthly oral Bonviva in ML19930, the BonAdAsia study. All patients completing 6 months in ML19930 will continue to receive Bonviva (150mg po, monthly) for an additional 6 months. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.

Clinical Details

Official title: An Open-Label, Clinical Observation Extension Study to Assess Continuing Safety and Adherence in Patients With Postmenopausal Osteoporosis Receiving Monthly Oral Bonviva

Study design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study

Primary outcome: SAEs, AEs including fractures, adherence to treatment, clinical improvement, osteoporosis symptoms

Eligibility

Minimum age: N/A. Maximum age: 85 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- patients responding to oral monthly Bonviva during the BonAdAsia study;

- willing to continue Bonviva treatment for a further 6 months.

Exclusion Criteria:

- none specified.

Locations and Contacts

HONG KONG 852, China

JAKARTA 10430, Indonesia

MAKASSAR 90174, Indonesia

SURABAYA 60286, Indonesia

MANILA 1015, Philippines

QUEZON CITY 1100, Philippines

TAICHUNG 407, Taiwan

TAINAN 704, Taiwan

CHANGHUA 500, Taiwan

TAICHUNG 404, Taiwan

TAOYUAN 333, Taiwan

TAIPEI 100, Taiwan

TAIPEI 112, Taiwan

BANGKOK 10400, Thailand

BANGKOK 10330, Thailand

CHIANG MAI 50200, Thailand

KHON KAEN 40002, Thailand

Additional Information


Ending date: June 2008
Last updated: June 17, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009